Abstract:Metastasis is a complex process that requires the interaction between tumor cells and their microenvironment. As an important regulator of intestinal microenvironment, gut microbiota plays a significant role in the initiation and progression of colorectal cancer (CRC), but the underlying mechanisms remain elusive. In this study, a metastasis-related secretory protein cathepsin K (CTSK) was identified as a vital mediator between the imbalance of intestinal microbiota and CRC metastasis. We implanted MC38 cells into the cecal mesentry of antibiotic-treated mice with intragastrically administration of E. coli to mimic gut microbiota imbalance. The bigger primary tumors and more liver metastatic foci were detected in the E. coli group accompanied with high LPS secretion and CTSK overexpression compared with that in the control group. CTSK contributes to the aggressive phenotype of CRC cells both in vitro and in vivo. Silencing CTSK or administration of Odanacatib, a CTSK-specific inhibitor, totally abolished the CTSK-enhanced migration and motility of CRC cells. Interestingly, the tumor-secreted CTSK could bind to toll-like receptor 4 (TLR4) to stimulate the M2 polarization of tumor-associated macrophages (TAMs) via an mTOR-dependent pathway. Recombinant CTSK could neither stimulate CRC growth and metastasis, nor induce M2 macrophage polarization in TRL4-/- mice. Meanwhile, CTSK could stimulate the secretion of cytokines by M2 TAMs including IL10 and IL17, which, in turn, promote the invasion and metastasis of CRC cells through NFκB pathway. Clinically, overexpression of CTSK in human CRC tissues is always accompanied with high M2 TAMs in the stroma, and correlated with CRC metastasis and poor prognosis. Our current research identified CTSK as a mediator between the imbalance of gut microbiota and CRC metastasis. More importantly, we illustrated a CTSK-mediated-positive feedback loop between CRC cells and TAMs during metastasis, prompting CTSK as a novel predictive biomarker and feasible therapeutic target for CRC.

A novel methylated cation channel TRPM4 inhibited colorectal cancer metastasis through Ca<SUP>2+</SUP>/Calpain-mediated proteolysis of FAK and suppression of PI3K/Akt/mTOR signaling pathway

TRIM67 inhibits tumor proliferation and metastasis by mediating MAPK11 in Colorectal Cancer

CMTM4 Inhibits Cell Proliferation and Migration Via AKT, ERK1/2, and STAT3 Pathway in Colorectal Cancer

Pharmacological manipulation of TRPC5 by kaempferol attenuates metastasis of gastrointestinal cancer via inhibiting calcium involved in the formation of filopodia

TRPC1 Promotes the Genesis and Progression of Colorectal Cancer Via Activating CaM-mediated PI3K/AKT Signaling Axis

TRPV4 Promotes Metastasis in Melanoma by Regulating Cell Motility through Cytoskeletal Rearrangement

DNA methylation mediated down-regulation of ANGPTL4 promotes colorectal cancer metastasis by activating the ERK pathway

Decreased expression of TRPM4 is associated with unfavorable prognosis and aggressive progression of endometrial carcinoma

Identification of TRPV4 as a novel target in invasiveness of colorectal cancer

Title Decreased TRPM 7 inhibits activities and induces apotosis ofbladder cancer cells via ERK 1 / 2 pathway

Gut microbiota-stimulated cathepsin K secretion mediates TLR4-dependent M2 macrophage polarization and promotes tumor metastasis in colorectal cancer

Inhibition of TMEM16A expression suppresses growth and invasion in human colorectal cancer cells.

Stimulating TRPM7 suppresses cancer cell proliferation and metastasis by inhibiting autophagy

The LCK-14-3-3ζ-TRPM8 Axis Regulates TRPM8 Function/assembly and Promotes Pancreatic Cancer Malignancy

Decreased TRPM7 Inhibits Activities and Induces Apoptosis of Bladder Cancer Cells Via ERK1/2 Pathway

MFAP2, Upregulated by M1a Methylation, Promotes Colorectal Cancer Invasiveness Via CLK3.

PRMT5 methylating SMAD4 activates TGF-β signaling and promotes colorectal cancer metastasis

1194 Down-regulated TRPV1 Expression Contributes to Melanoma Growth Via Calcineurin-Atf3-p53 Pathway

TRPM7 Deficiency Suppresses Cell Proliferation, Migration, and Invasion in Human Colorectal Cancer Via Regulation of Epithelial-Mesenchymal Transition.

Transcriptional dysregulation of TRIM29 promotes colorectal cancer carcinogenesis via pyruvate kinase-mediated glucose metabolism

KCNN4 Channels Participate in the EMT Induced by PRL-3 in Colorectal Cancer